Back to Shelton Capital Management Shelton Capital Management

MRNAMRNA

Showing 7 of 26 quarters

Position history for Shelton Capital ManagementShelton Capital Management's holdings in Moderna, Inc.

No. Shelton Capital Management exited its MRNA (Moderna) position in Q1 2026. Its Q4 2025 13F listed 9,493 shares worth $279,949. Shelton Capital Management first reported MRNA in Q4 2019 and held it in 25 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$3.9M

Total Shares Change

-57,984

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$49.83
0
2025-Q4
Unchanged
9,493
0.0%
$279,9490.0%$30.41
0
2025-Q3
Unchanged
9,493
0.0%
$245,2040.0%$25.33
0
2025-Q2
Decreased
9,493
-1.9%
$261,9120.0%$27.16
0
2025-Q1
Decreased
9,672
-17.1%
$274,2010.0%$31.12
0
2024-Q4
Decreased
11,672
-79.9%
$485,3220.0%$39.38
0
2024-Q3
Increased
57,984
+1.6%
$3.9M0.1%$65.75
27

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used